Sfoglia per AUTORE
CATTANEO D
Collezione ASL Città di Torino

  

Items : 9

Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2024 May 2;79(5):1126-1132. doi: 10.1093/jac/dkae080.
2024
ASL Città di Torino

Cossu MV; Cattaneo D; Moschese D; Giacomelli A; Soloperto S; D'Avolio A; Antinori S; Gori A; Rizzardini G; Gervasoni C;

Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2024 May 2;68(5):e0017524. doi: 10.1128/aac.00175-24. Epub 2024 Mar 27.
2024
ASL Città di Torino

Cossu MV; D'Avolio A; Gervasoni C; Giacomelli A; Cattaneo D; Moschese D;

Tenofovir Plasma Trough Concentrations in People Living with HIV Treated with Tenofovir Disoproxyl Fumarate: Antiretroviral Class or Individual Drug Effect? in Therapeutic drug monitoring / Ther Drug Monit. 2023 Apr 1;45(2):282-284. doi: 10.1097/FTD.0000000000001072. Epub 2023 Jan 10.
2023
ASL Città di Torino

Cattaneo D; Bonora S; Meraviglia P; Vimercati S; Antinori S; Gervasoni C;

Therapeutic drug monitoring of TNF? inhibitors: a spotlight on novel techniques and assays. in Expert opinion on drug metabolism & toxicology / Expert Opin Drug Metab Toxicol. 2022 Oct;18(10):615-618. doi: 10.1080/17425255.2022.2134775. Epub 20
2022
ASL Città di Torino

Cusato J; Cattaneo D;

Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2021 Jan 1;65(1):e01902-20. doi: 10.1128/AAC.01902-20. Epub 2020 Oct 26
2021
ASL Città di Torino

Calcagno A; Dal Conte I; Cattaneo D; Testi R; Mistrangelo M; Gervasoni C; de Nicolò A; Bonora S; D'Avolio A; Di Perri G;

Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV. in Clinical pharmacokinetics / Clin Pharmacokinet. 2021 Jan;60(1):103-109. doi: 10.1007/s40262-020-00916-9.
2021
ASL Città di Torino

Calcagno A; Moltó J; Borghetti A; Gervasoni C; Milesi M; Valle M; Avataneo V; Alcantarini C; Pla-Junca F; Trunfio M; D'Avolio A; Di Giambenedetto S; Cattaneo D; Di Perri G; Bonora S;

Therapeutic Drug Monitoring of Dalbavancin Treatment in Severe Necrotizing Fasciitis in 3 Critically Ill Patients: A Grand Round. in Therapeutic drug monitoring / Ther Drug Monit. 2020 Apr;42(2):165-168. doi: 10.1097/FTD.0000000000000729.
2020
ASL Città di Torino

D'Avolio A; Cattaneo D; Veronese A; Corona A; Agarossi A;

Darunavir-based Antiretroviral Therapy may Affect the Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in HCV/HIV-1 Coinfected Patients. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2016 Jul 15;63(2):285-6. doi: 10.1093/cid/ciw292. Epub 2016 May 3.
2016
ASL Città di Torino

Sollima S; D'Avolio A; Cattaneo D; Micheli V; Milazzo L; Gervasoni C;

Pharmacokinetic interactions between telaprevir and antiretroviral drugs in HIV/HCV-coinfected patients with advanced liver fibrosis and prior HCV non-responders. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2015 May;45(5):545-9. doi: 10.1016/j.ijantimicag.2014.12.035. Epub 2015 Feb
2015
ASL Città di Torino

Milazzo L; Cattaneo D; Calvi E; Gervasoni C; Mazzali C; Ronzi P; Peri AM; Ridolfo AL; D'Avolio A; Antinori S;